Risk-Benefit Analysis Methods for Pharmaceutical Decision-Making - Where Are We Now?

Albert Hauber; F Johnson; EA Andrews

RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Risk-Benefit Analysis Methods for Pharmaceutical Decision-Making - Where Are We Now?

Hauber, A., Johnson, F., & Andrews, EA. (2006). Risk-Benefit Analysis Methods for Pharmaceutical Decision-Making - Where Are We Now? ISPOR Connections, 12(6), 3-5.

Copy citation

Recent Publications

Article

"Show Me the Energy Costs"

Article

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure-A systematic review

Article

Variation in estimates of heat-related mortality reduction due to tree cover in US cities

Article

Promoting reproducibility and increased collaboration in electric sector capacity expansion models with community benchmarking and intercomparison efforts

Risk-Benefit Analysis Methods for Pharmaceutical Decision-Making - Where Are We Now?

Publications Info

Recent Publications

Article

"Show Me the Energy Costs"

Article

Effectiveness of interventions for the remediation of lead-contaminated soil to prevent or reduce lead exposure-A systematic review

Article

Variation in estimates of heat-related mortality reduction due to tree cover in US cities

Article

Promoting reproducibility and increased collaboration in electric sector capacity expansion models with community benchmarking and intercomparison efforts